On Invalid Date, MERCK & (NYSE: MRK) reported Q1 2022 earnings per share (EPS) of $1.70, up 34.92% year over year. Total MERCK & earnings for the quarter were $4.31 billion. In the same quarter last year, MERCK &'s earnings per share (EPS) was $1.26.
What was MRK's earnings growth in the past year?
As of Q2 2022, MERCK &'s earnings has grown 101.8% year over year. This is 4.51 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 97.28%. MERCK &'s earnings in the past year totalled $14.18 billion.
What was MRK's revenue last quarter?
On Invalid Date, MERCK & (NYSE: MRK) reported Q1 2022 revenue of $15.90 billion up 49.63% year over year. In the same quarter last year, MERCK &'s revenue was $10.63 billion.
What was MRK's revenue growth in the past year?
As of Q2 2022, MERCK &'s revenue has grown 28.96% year over year. This is 4.05 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 24.91%. MERCK &'s revenue in the past year totalled $53.98 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.